|
시장보고서
상품코드
2112605
외과용 로봇 시장 : 개발 기업의 제공 제품 및 서비스, 도입 모델, 대응 외과수술, 용도, 최종사용자, 주요 지역별 동향 및 예측(-2035년)Surgical Robots Market by Offering of Surgical Robot Developers, Deployment Model, Type of Surgical Procedure Supported, Application Area, End Users and Key Geographical Regions - Trends and Forecast Till 2035 |
||||||
Roots Analysis의 조사에 따르면 세계의 외과용 로봇 시장 규모는 올해 106억 달러에서 2035년까지 229억 달러로 성장할 것으로 추정되고 있으며, 예측 기간 중 CAGR은 약 8.9%에 달할 전망입니다.

수술용 로봇 시장: 성장 및 동향
수술용 로봇 시장은 최소 침습 수술의 보급 확대와 더 높은 수술 정밀도에 대한 수요 증가에 힘입어 견고한 성장을 달성하고 있습니다. 로봇 보조 시스템은 조작성 향상, 임상 결과 개선, 환자 부담 경감, 수술 후 회복 촉진과 같은 이점으로 인해 일반 외과, 정형외과,비뇨기과, 복부 및 골반외과수술에서 점점 더 널리 도입되고 있습니다. 이러한 장점 덕분에 외과용 로봇은 현대 외과 의료에서 중요한 요소로서의 입지를 확고히 하고 있습니다.
로봇 플랫폼에 AI와 첨단 영상 기술을 통합함으로써 실시간 수술 안내, 운동 제어 향상, 수술 중 의사결정 지원 강화를 가능하게 하여 경쟁 구도를 새롭게 바꾸고 있습니다. 또한 원격 조작형 및 클라우드/원격 대응 시스템의 등장으로 인해 그동안 전문 외과의사에게 접근하기 어려웠던 지역에서도 로봇 수술을 활용할 수 있게 되고 있습니다.
또한 각 개발사는 수술실내 점유 면적 및 설비 투자 부담을 줄이기 위한 소형화도 추진하고 있으며, 도입 대상이 되는 병원 및 외래 수술 센터의 기반을 확대하고 있습니다. 외과용 로봇 시스템의 도입이 다양한 전문 분야와 지역으로 계속 확산되는 가운데, 자본 설비 판매에 더해 소모품, 부속품, 서비스 계약을 통한 지속적인 수익이 장기적인 시장 성장을 유지하는 데 있으며, 점점 더 중요한 역할을 하고 있습니다.
성장의 원동력: 시장 확대를 지원하는 요인
외과용 로봇 시장은 정밀도 향상, 출혈량 감소, 수술 후 감염 위험 저하, 환자의 조기 회복 등 기존의 개복 수술이나 복강경 수술과 비교했을 때 로봇 보조 수술이 가져다주는 임상적 이점에 의해 주도되고 있습니다. AI, 기계학습, 의료 영상 기술의 통합이 진행됨에 따라 수술 전 계획 및 수술 중 의사결정이 개선되어, 외과의사들이 이러한 시스템에 대한 신뢰도가 더욱 높아지고 있습니다.
서비스와 교육을 결합한 제공 모델은 초기 자본 부담을 줄여줌으로써 병원의 도입 장벽을 낮추고 있습니다. 동시에, 이러한 프로그램을 장비 판매와 연계함으로써 장기적인 시장 성장을 지원하는 지속적인 관계가 형성되고 있습니다.
시장 규모 및 기회 분석은 다음 매개변수를 기반으로 분류됩니다.
수술용 로봇 개발 기업의 제공 제품 및 서비스별
도입 모델별
대응 가능한 외과수술별
용도별
최종사용자별
지역별
수술용 로봇 시장: 주요 부문 분석
제공 제품 및 서비스별로는 기구·부속품이 주도
Roots Analysis사의 시장 평가에 따르면 제공 제품 및 서비스별로는 기구 및 부속품이 가장 큰 점유율을 차지할 것으로 예상됩니다. 이 부문이 주도적인 위치를 차지하는 주요 요인은 일회용 및 재사용 가능한 로봇 수술 기구, 엔드 이펙터, 스테이플러, 에너지 장치, 카메라, 시각화 구성 요소 등에 대한 지속적인 수요가 있다는 점입니다. 이러한 제품들은 일정 횟수의 수술을 거친 후 정기적인 교체가 필요합니다.
일회성 설비 투자인 로봇 플랫폼과 달리, 기구 및 부속품은 수술 건수와 직결된 지속적인 수익을 창출하므로 제조사의 장기적인 수익에 크게 기여하고 있습니다. 또한 일반외과, 비뇨기과, 산부인과, 정형외과 등의 전문 분야에서 로봇 보조 수술 건수가 증가하고 있는 것이 이러한 고부가가치 소모품에 대한 수요를 지속적으로 견인하고 있습니다.
한편, 서비스 부문은 예측 기간 중 가장 높은 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다. 이 분야의 성장은 전 세계 로봇 수술 시스템 도입 건수의 확대에 힘입어 유지보수 계약, 소프트웨어 업그레이드, 기술 지원, 예방 정비에 대한 지속적인 수요를 창출하고 있습니다.
또한 병원 및 의료 기관에서는 수술 효율화와 환자 예후 개선을 도모하기 위해 외과 의사 인증 프로그램, 시뮬레이션 기반 훈련, 수술실 직원 교육에 대한 투자를 점점 더 늘리고 있습니다. 신흥 시장에서 로봇 수술의 도입 확대 역시 설치, 시운전, 사후 서비스에 대한 수요를 가속화할 것으로 예상되며, 이는 해당 부문의 성장 전망을 더욱 공고히 할 것입니다.
북미가 시장을 주도하고, 아시아태평양이 가장 빠른 성장세를 기록
북미는 전 세계 외과용 로봇 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다. 이 지역은 주요 로봇 수술 개발 기업의 존재, 견고한 의료 인프라, 유리한 보험 급여 제도, 최소 침습 수술의 광범위한 보급 등의 혜택을 누리고 있습니다. 높은 의료비 지출, 첨단 의료 기술의 조기 도입, 기존 기업과 신생 제조업체 모두의 로봇 기술 혁신에 대한 지속적인 투자가 이 지역의 시장 입지를 더욱 공고히 하고 있습니다. 또한 고도로 훈련된 로봇 외과 의사의 확보와 확립된 임상 연수 프로그램의 존재가 여러 외과 전문 분야에서 수술 건수의 지속적인 증가를 지원하고 있습니다.
한편, 아시아태평양 시장은 예측 기간 중 가장 높은 연평균 성장률(CAGR)을 기록할 것으로 전망됩니다. 의료 인프라의 급속한 확대, 의료비 증가, 로봇 보조 수술에 대한 의식의 향상, 국내 의료기기 제조를 지원하는 정부의 우호적인 정책이 이 지역의 성장을 촉진하고 있습니다. 중국, 일본, 한국, 인도 등에서는 로봇 수술의 연구, 제조, 상용화에 대한 투자가 증가하고 있을 뿐만 아니라, 경쟁력 있는 가격으로 로봇 플랫폼을 제공하는 지역 제조사들도 두각을 보이고 있습니다. 또한 병원 네트워크의 확대, 수술 건수의 증가, 첨단 의료 기술에 대한 접근성 개선으로 인해 지역 전반에 걸쳐 수술용 로봇 시스템의 도입이 가속화될 것으로 예상됩니다.
이 보고서에서는 전 세계 외과용 로봇 시장을 조사하여 시장 개요, 배경, 시장 영향 요인 분석, 시장 규모 추이 및 전망, 각종 분류별 상세 분석, 경쟁 구도, 주요 기업 개요 등을 정리하여 전해드립니다.
As per Roots Analysis, the global surgical robots market is estimated to grow from USD 10.6 billion in the current year to USD 22.9 billion by 2035, reflecting a compound annual growth rate (CAGR) of approximately 8.9% during the forecast period.

Surgical Robots Market: Growth and Trends
The surgical robotics market is witnessing robust growth, driven by the increasing adoption of minimally invasive procedures and the rising demand for greater surgical precision. Robotic-assisted systems are being increasingly integrated across general, orthopedic, urologic, abdominal and pelvic surgeries, owing to their ability to enhance dexterity, improve clinical outcomes, minimize patient trauma, and accelerate post-operative recovery. These advantages position surgical robots as a key component of modern surgical care.
The integration of artificial intelligence and advanced imaging into robotic platforms is reshaping the competitive landscape as it enables real-time surgical guidance, improved motion control and stronger intra-operative decision support. Additionally, the emergence of tele-operated and cloud / remote-enabled systems is extending robotic surgery capabilities to geographies that have historically lacked access to specialist surgeons.
Developers are also pursuing miniaturization to reduce operating-room footprint and capital intensity, broadening the addressable base of hospitals and ambulatory surgery centers. As the adoption of surgical robotic systems continues to broaden across multiple specialties and geographies, recurring revenues from consumables, accessories and service contracts are playing an increasingly important role in sustaining long-term market growth, in addition to capital equipment sales.
Growth Drivers: Factors Fueling Market Expansion
The surgical robots market is being propelled by the clinical advantages robotic-assisted procedures offer over conventional open and laparoscopic surgery, including improved precision, reduced blood loss, lower risk of post-operative infection and faster patient recovery. The growing integration of artificial intelligence, machine learning and medical imaging technologies is further strengthening surgeon confidence in these systems by improving pre-operative planning and intra-operative decision-making.
Service and training models lower adoption barriers for hospitals by reducing upfront capital burdens. At the same time, bundling these programs with equipment sales creates recurring commercial relationships that support long-term market growth.
Market Challenges: Critical Barriers Hindering Progress
Despite favorable growth prospects, the market faces several challenges that may hinder overall growth in the future. High capital costs associated with robotic systems and compatible instruments continue to limit adoption among smaller hospitals and ambulatory surgery centers, particularly in price-sensitive geographies. Reimbursement frameworks for robotic-assisted procedures also remain inconsistent across countries, creating uncertainty for developers and distribution partners evaluating market entry.
Developing autonomous surgical robots involves severe technical complexities. No fully autonomous systems yet approved by regulatory authorities, the clearance pathway for next-generation AI platforms remains uncertain. Intensifying competition from lower-cost, portable new entrants is also compressing pricing for established players, adding pressure on installed base and service revenue.
Surgical Robots Market: Key Insights
The report delves into the current state of the Surgical Robots market and identifies potential growth opportunities within the industry, particularly from a distributor and channel-partner perspective. Some key findings include:
Surgical Robots Market Segments
Roots Analysis segments the global Surgical Robots opportunity across the following parameters:
By Offering of Surgical Robot Developers
By Deployment Model
By Type of Surgical Procedure Supported
By Application Area
By End Users
By Geographical Regions
Surgical Robots Market: Key Segments Insight
Instruments / Accessories Lead the Offering Segment
According to the Roots Analysis market assessment, instruments and accessories are expected to account for the largest share of the surgical robots market. The dominance of this segment is primarily attributed to the recurring demand for disposable and reusable robotic instruments, end-effectors, staplers, energy devices, cameras and visualization components that require periodic replacement after a defined number of procedures.
Unlike robotic platforms, which represent one-time capital investments, instruments and accessories generate continuous revenue streams linked directly to procedural volumes, making them a significant contributor to manufacturers' long-term revenues. Furthermore, the increasing number of robot-assisted procedures across specialties such as general surgery, urology, gynecology and orthopedics continues to drive demand for these high-value consumables.
Meanwhile, the services segment is projected to witness the highest CAGR during the forecast period. Growth in this segment is supported by the expanding global installed base of robotic surgical systems, creating sustained demand for maintenance contracts, software upgrades, technical support and preventive servicing.
Additionally, hospitals and healthcare institutions are increasingly investing in surgeon certification programs, simulation-based training and operating room staff education to improve procedural efficiency and patient outcomes. The growing adoption of robotic surgery in emerging markets is also expected to accelerate demand for installation, commissioning and post-sales support services, further strengthening the growth prospects of this segment.
General Surgery Captures the Largest Share by Procedure Type
General surgery is anticipated to capture the largest share of the surgical robots market. This leadership is driven by the broad range of minimally invasive procedures performed within the specialty, including colorectal, bariatric, gastrointestinal, abdominal wall reconstruction and hepatobiliary surgeries. Robotic platforms offer surgeons superior dexterity, enhanced three-dimensional visualization, improved precision and greater instrument articulation, enabling complex procedures to be performed with reduced blood loss, fewer complications and shorter hospital stays. The rising global burden of gastrointestinal disorders and obesity, coupled with increasing patient preference for minimally invasive surgical techniques, continues to support widespread adoption of robotic systems in general surgery.
On the other hand, the orthopedic surgery segment is expected to register the highest CAGR over the forecast period. Growth is being fuelled by increasing adoption of robotic-assisted joint replacement procedures, particularly knee and hip arthroplasty, where robotic guidance enhances implant positioning and surgical accuracy.
Furthermore, manufacturers are introducing compact robotic platforms specifically designed for orthopedic applications, requiring smaller operating room footprints while improving workflow efficiency. The industry's gradual transition toward open-instrument business models, allowing greater compatibility with diverse implant systems and surgical tools. This transition is also encouraging broader adoption across hospitals and specialty orthopedic centres.
On-Premise Deployment Dominates and Cloud-Based Grow at Higher CAGR
The on-premise deployment segment is expected to account for the largest share of the surgical robots market. Most healthcare providers continue to favour on-site deployment owing to its ability to provide direct system control, low-latency performance, enhanced cybersecurity and seamless integration with hospital information systems, imaging infrastructure and electronic medical records. In addition, stringent regulatory requirements surrounding patient data security and surgical workflow reliability have reinforced the preference for locally deployed robotic platforms in high-acuity healthcare settings.
Conversely, the cloud / remote deployment segment is projected to grow at a higher CAGR during the forecast period. Advances in high-speed connectivity, edge computing, artificial intelligence and secure cloud infrastructure are enabling greater adoption of remote surgical assistance, tele-mentoring and tele-operated robotic procedures. These technologies have the potential to bridge geographical barriers by allowing experienced surgeons to support or perform procedures across distant locations, improving access to specialized surgical care in underserved regions. As communication networks continue to evolve and regulatory frameworks mature, cloud-enabled robotic ecosystems are expected to play an increasingly important role in expanding access to robotic surgery worldwide.
Therapies / Treatment Applications Lead the Market
The therapies / treatment segment is expected to capture the largest share of the surgical robots market and maintain its leadership throughout the forecast period. Surgical robotic systems are predominantly utilized for therapeutic interventions across multiple specialties, including oncology, cardiovascular surgery, gynecology, urology and general surgery. The growing adoption of minimally invasive procedures and the superior precision of robotic systems continue to drive demand for robotic-assisted therapeutic procedures. Increasing investments in advanced robotic technologies and expanding clinical indications further reinforce the dominance of this application segment.
The diagnostics segment is anticipated to grow at a higher CAGR during the forecast period. Robotic technologies are increasingly being integrated into image-guided biopsy procedures, endoscopic examinations and precision diagnostic interventions that require high levels of accuracy and reproducibility. Furthermore, advances in robotic imaging platforms, navigation technologies and artificial intelligence-assisted diagnostic systems are expected to expand the role of robotics beyond therapeutic applications. As healthcare providers increasingly adopt precision medicine approaches and minimally invasive diagnostic techniques, demand for robotic-assisted diagnostic solutions is likely to grow steadily.
Hospitals Remain the Dominant End User
Hospitals are expected to remain the largest end-user segment in the surgical robots market throughout the forecast period. Large tertiary care hospitals and academic medical centres account for the majority of robotic system installations owing to their higher surgical volumes, greater financial capacity and availability of specialized surgical teams. Hospitals continue to invest heavily in robotic technologies to improve clinical outcomes, reduce complication rates, shorten hospital stays and enhance overall patient satisfaction.
Ambulatory surgery centres and diagnostic labs are also gradually expanding their use of robotic technologies. However, their adoption remains comparatively limited due to higher capital investment requirements and the complexity of integrating robotic systems into outpatient settings. Nevertheless, ongoing technological advancements leading to more compact, cost-effective robotic platforms are expected to support gradual expansion into these healthcare facilities over the coming years.
North America Leads the Market and Asia-Pacific Registers the Fastest Growth
North America is expected to account for the largest share of the global surgical robots market. The region benefits from the presence of leading robotic surgery developers, strong healthcare infrastructure, favourable reimbursement frameworks and widespread adoption of minimally invasive surgical procedures. High healthcare expenditure, early adoption of advanced medical technologies and continuous investments in robotic innovation by both established companies and emerging manufacturers continue to strengthen the region's market position. In addition, the availability of highly trained robotic surgeons and well-established clinical training programmes supports sustained procedural growth across multiple surgical specialties.
Meanwhile, Asia-Pacific market is projected to register the highest CAGR during the forecast period. Rapid expansion of healthcare infrastructure, increasing healthcare expenditure, growing awareness of robotic-assisted surgery and favourable government initiatives supporting domestic medical device manufacturing are driving regional growth. Countries such as China, Japan, South Korea and India are witnessing increasing investments in robotic surgery research, production and commercialization, alongside the emergence of regional manufacturers offering competitively priced robotic platforms. Furthermore, expanding hospital networks, rising surgical procedure volumes and improving access to advanced healthcare technologies are expected to accelerate the adoption of surgical robotic systems across the region.
Expert Interview and Industry Insights
The opinions and insights presented in this study were shaped by discussions with multiple stakeholders across the value chain. The research report features detailed transcripts of interviews held with the following industry participants:
Key Questions Answered in this Report
Reasons to Buy this Report
This report has been specifically developed to support distributors, channel partners, and business development teams evaluating entry into the Surgical Robots market.
Additional Benefits